Historical record - last NADAC effective date: 11/22/2017
Product Information
GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.0461 per EA under NDC 23155023305. Its NADAC has been published 235 times since Nov 28, 2013.
FDA first approved this application on Jun 3, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25; 250 mg/1; mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155023305
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
11/22/2017
Active Ingredients
GLYBURIDE; METFORMIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA079009FDA Approved
6/3/2009
TE Code
AB
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has been published 235 times since Nov 28, 2013, and over the history we have for it it has declined 47.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0461 per EA |
|---|---|
| All-time high | $0.0908 (May 11, 2016) |
| All-time low | $0.0461 (Nov 22, 2017) |
| Median price | $0.0717 |
| Average price | $0.0698 |
| Largest weekly change | +37.5% (Jun 22, 2016) |
| Weeks tracked | 235 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-47.3%
Last surveyed May 23, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET, manufactured by Heritage Pharmaceuticals Inc., is $0.0461 per EA (NDC 23155023305), effective May 23, 2018.
How has the price of GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET changed over time?
Over the history we have for it, the NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has declined 47.3%. It has been tracked across 235 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
Since Nov 28, 2013, the NADAC for GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET has ranged from a low of $0.0461 (Nov 22, 2017) to a high of $0.0908 (May 11, 2016), with a median of $0.0717 per EA.
Are there cheaper alternatives to GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET, is $0.0335 per EA — about 27% below GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET.
Who manufactures GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET?
GLYBURIDE-METFORMIN 1.25 MG-250 MG TABLET (NDC 23155023305) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.